OpenAlex | Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease

Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease

Work

Year: 2022

Type: article

Source: Structural Chemistry

Authors Yufei Feng, Xiaoning Cheng, Shuilong Wu, Konda Mani Saravanan, Wenxin Liu

Institutions Lingnan Normal University, Central People's Hospital of Zhanjiang, Bharath University

Cites: 70

Cited by: 4

Related to: 10

FWCI: 0.492

Citation percentile (by year/subfield): 55.24

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal Good health and well-being

Open Access status: bronze